NO20090439L - Vaksiner og metoder for a kontrollere adipositet - Google Patents

Vaksiner og metoder for a kontrollere adipositet

Info

Publication number
NO20090439L
NO20090439L NO20090439A NO20090439A NO20090439L NO 20090439 L NO20090439 L NO 20090439L NO 20090439 A NO20090439 A NO 20090439A NO 20090439 A NO20090439 A NO 20090439A NO 20090439 L NO20090439 L NO 20090439L
Authority
NO
Norway
Prior art keywords
adiposity
vaccines
methods
control
immune conjugates
Prior art date
Application number
NO20090439A
Other languages
English (en)
Norwegian (no)
Inventor
Kim D Janda
Eric P Zorrilla
Michael M Meijler
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20090439L publication Critical patent/NO20090439L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20090439A 2006-08-01 2009-01-29 Vaksiner og metoder for a kontrollere adipositet NO20090439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82107106P 2006-08-01 2006-08-01
PCT/US2007/074976 WO2008016976A2 (fr) 2006-08-01 2007-08-01 Vaccins et procédés pour controller l'adiposité

Publications (1)

Publication Number Publication Date
NO20090439L true NO20090439L (no) 2009-03-19

Family

ID=38997839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090439A NO20090439L (no) 2006-08-01 2009-01-29 Vaksiner og metoder for a kontrollere adipositet

Country Status (15)

Country Link
US (1) US9675679B2 (fr)
EP (1) EP2046376B1 (fr)
JP (1) JP2009545618A (fr)
KR (1) KR101510082B1 (fr)
CN (1) CN101500602A (fr)
AU (1) AU2007281131B2 (fr)
BR (1) BRPI0715345A8 (fr)
CA (1) CA2659264C (fr)
CR (1) CR10644A (fr)
EA (1) EA200970166A1 (fr)
IL (1) IL196720A0 (fr)
MA (1) MA30637B1 (fr)
MX (1) MX2009001133A (fr)
NO (1) NO20090439L (fr)
WO (1) WO2008016976A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992928B2 (en) 2006-02-11 2015-03-31 Victor Raso Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin
WO2010089757A2 (fr) * 2008-11-07 2010-08-12 Usv Limited Procédé amélioré de synthèse d'un octapeptide cyclique
CA2826853C (fr) * 2011-02-09 2020-10-27 The Scripps Research Institute Immunoconjugues d'haptene polypeptidique mimetique de ghreline ayant une solubilite et une immunogeneicite ameliorees et leurs procedes d'utilisation
WO2013119800A1 (fr) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Utilisation d'antagonistes de ghréline ou de récepteur de ghréline pour prévenir ou traiter une maladie psychiatrique sensible au stress
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
WO2017170494A1 (fr) * 2016-03-29 2017-10-05 国立大学法人東京大学 Vaccin contre l'obésité

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596792A (en) 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
JPS5938877A (ja) 1982-08-30 1984-03-02 Musashi Eng Kk 紙葉判別方法
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
CA2380058C (fr) * 1999-07-23 2011-08-09 Kenji Kangawa Nouveaux peptides
GB2357084A (en) * 1999-12-06 2001-06-13 Amersham Pharm Biotech Uk Ltd A hydrophobic carrier peptide
CA2411667A1 (fr) * 2000-05-30 2001-12-06 Merck & Co. Inc. Analogues de la ghreline
RU2325202C2 (ru) * 2002-07-19 2008-05-27 Цитос Байотекнолоджи Аг Конъюгаты грелин-носитель
EP1407779A1 (fr) * 2002-10-10 2004-04-14 Gastrotech A/S Utilisation de ghrelin pour traitement de poids corporel réduit et de graisse corporelle réduite dans des individus avec gastrectomie
SG149013A1 (en) * 2003-12-17 2009-01-29 Wyeth Corp Immunogenic peptide carrier conjugates and methods of producing same
EP1706152A2 (fr) * 2004-01-20 2006-10-04 Cytos Biotechnology AG Conjugues a base de ghreline et d'un vehicule
JP2007532495A (ja) * 2004-04-07 2007-11-15 ガストロテック・ファルマ・アクティーゼルスカブ グレリン欠乏を治療するための分泌促進薬の使用
US20070237775A1 (en) * 2004-07-14 2007-10-11 Eli Lilly And Company Anti-Ghrelin Antibodies
NZ554386A (en) * 2004-10-25 2009-12-24 Cytos Biotechnology Ag Gastric inhibtory polypeptide (GIP) antigen arrays with VLPs and uses thereof
US8992928B2 (en) * 2006-02-11 2015-03-31 Victor Raso Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin

Also Published As

Publication number Publication date
WO2008016976A8 (fr) 2009-08-06
JP2009545618A (ja) 2009-12-24
EP2046376A4 (fr) 2010-01-27
EA200970166A1 (ru) 2009-06-30
WO2008016976A3 (fr) 2008-09-25
CR10644A (es) 2009-04-16
MA30637B1 (fr) 2009-08-03
AU2007281131B2 (en) 2012-11-29
IL196720A0 (en) 2011-08-01
BRPI0715345A8 (pt) 2019-01-08
KR20090041416A (ko) 2009-04-28
CA2659264C (fr) 2016-01-26
US20100021487A1 (en) 2010-01-28
AU2007281131A1 (en) 2008-02-07
BRPI0715345A2 (pt) 2013-06-18
WO2008016976B1 (fr) 2008-11-06
MX2009001133A (es) 2009-02-11
CN101500602A (zh) 2009-08-05
KR101510082B1 (ko) 2015-04-10
CA2659264A1 (fr) 2008-02-07
EP2046376A2 (fr) 2009-04-15
US9675679B2 (en) 2017-06-13
WO2008016976A2 (fr) 2008-02-07
EP2046376B1 (fr) 2018-08-01

Similar Documents

Publication Publication Date Title
NO20084356L (no) Anti TAT226-antistoffer og immunokonjugater
NO20085396L (no) Antistoffer og immunkonjugater, og anvendelser derav
DK3276349T3 (da) Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåder til fremstilling og anvendelse deraf
CY1123035T1 (el) Μεθοδοι και συνθεσεις με βαση συζευγματα τοξινης της διφθεριτιδας-ιντερλευκινης-3
DK2176296T3 (da) Anti-CD79B-antistoffer og immunkonjugater og anvendelsesfremgangsmåder.
DK2921500T5 (da) Genetisk modificerede, humane, naturlige dræbercellelinjer
DE602005020837D1 (de) Il-7-varianten mit reduzierter immunogenität
DK2124613T3 (da) Sammensætninger og fremgangsmåder til kontrol af kæledyrs vægt
NO20092186L (no) Faktor IX del-polymer konjugater med en utlosbar binding
WO2007079190A3 (fr) Dispositif et procede renforçant la reponse immunitaire par stimulation electrique
NO20083891L (no) Anti-5T4 antistoffer og anvendelser derav
PH12021552853A1 (en) Antibody drug conjugates
CY1116261T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
DK1960434T3 (da) Monoklonale, humane antistoffer mod Fucosyl-GM1 og fremgangsmåder til anvendelse af anti-Fucosyl-GM1
ZA200609500B (en) Adjuvanted Shiga toxin B-subunit based vaccines
WO2008079973A9 (fr) Peptides de liaison au récepteur egf et utilisations de ces derniers
NO20074378L (no) Elektromagnetisk telemetrianordning og fremgangsmåte for å minimalisere syklisk eller synkron støy
NO20090305L (no) Cyklosporin formuleringer
DK2049097T3 (da) Sammensætning og fremgangsmåde til at binde acetaldehyd i maven
ZA202304464B (en) Antibody drug conjugates
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
WO2010056144A3 (fr) Cellules t tueuses naturelles foxp3+ et traitement des maladies associées à l’immunité
NO20060480L (no) Nano-baserte anordninger til bruk i en bronn
CR10644A (es) Vacunas y metodos para controlar adiposidad
NO20061121L (no) Konjugater av hydroksyalkystivelse og G-CSF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application